The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Williams Kristen since 2016.
This trader's CIK number is 1296965.
At the time of last reporting, Williams Kristen was the Chief Administrative Officer of Pacira Biosciences, Inc.. (stock ticker symbol PCRX).
Also see all insider trading activities at Pacira Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PCRX | 0 | $0 | 14,376 | $377,226 | 0 | $0 |
| 2024 | PCRX | 0 | $0 | 7,452 | $211,487 | 0 | $0 |
| 2023 | PCRX | 0 | $0 | 9,125 | $341,582 | 0 | $0 |
| 2022 | PCRX | 0 | $0 | 44,770 | $2,945,441 | 36,152 | $1,540,651 |
| 2021 | PCRX | 0 | $0 | 31,442 | $2,048,920 | 21,823 | $864,409 |
| 2020 | PCRX | 0 | $0 | 91,883 | $5,394,376 | 83,577 | $3,322,685 |
| 2019 | PCRX | 0 | $0 | 8,781 | $355,410 | 0 | $0 |
| 2018 | PCRX | 0 | $0 | 6,813 | $291,881 | 0 | $0 |
| 2017 | PCRX | 0 | $0 | 36,379 | $1,678,670 | 31,041 | $468,169 |
| 2016 | PCRX | 0 | $0 | 600 | $28,319 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-04 | PCRX | Sale | 14,376 | 26.24 | 377,226 |
| 2024-06-13 | PCRX | Sale | 7,452 | 28.38 | 211,487 |
| 2023-06-14 | PCRX | Sale | 6,467 | 37.03 | 239,473 |
| 2023-06-06 | PCRX | Sale | 1,301 | 38.99 | 50,727 |
| 2023-06-07 | PCRX | Sale | 1,357 | 37.87 | 51,382 |
| 2022-06-07 | PCRX | Sale | 4,649 | 59.51 | 276,661 |
| 2022-06-06 | PCRX | Sale | 3,969 | 61.37 | 243,593 |
| 2022-03-21 | PCRX | Option Ex | 7,253 | 43.18 | 313,184 |
| 2022-03-21 | PCRX | Sale | 7,253 | 72.67 | 527,075 |
| 2022-02-16 | PCRX | Sale | 10 | 65.00 | 650 |
| 2022-02-25 | PCRX | Sale | 2,050 | 66.03 | 135,371 |
| 2022-02-16 | PCRX | Option Ex | 10 | 38.35 | 383 |
| 2022-02-25 | PCRX | Option Ex | 2,050 | 38.35 | 78,617 |
| 2022-02-04 | PCRX | Option Ex | 1,000 | 38.35 | 38,350 |
| 2022-02-04 | PCRX | Sale | 1,000 | 65.18 | 65,180 |
| 2022-01-21 | PCRX | Sale | 200 | 65.41 | 13,082 |
| 2022-01-21 | PCRX | Option Ex | 200 | 38.35 | 7,670 |
| 2022-01-19 | PCRX | Sale | 2,199 | 65.51 | 144,056 |
| 2022-01-18 | PCRX | Sale | 23,440 | 65.69 | 1,539,773 |
| 2022-01-18 | PCRX | Option Ex | 23,440 | 43.44 | 1,018,116 |
| 2022-01-19 | PCRX | Option Ex | 2,199 | 38.35 | 84,331 |
| 2021-06-10 | PCRX | Sale | 5,689 | 60.00 | 341,340 |
| 2021-06-04 | PCRX | Sale | 3,930 | 61.04 | 239,875 |
| 2021-04-13 | PCRX | Option Ex | 21,823 | 39.61 | 864,409 |
| 2021-04-13 | PCRX | Sale | 21,823 | 67.25 | 1,467,705 |
| 2020-09-17 | PCRX | Sale | 27,871 | 59.99 | 1,672,120 |
| 2020-09-16 | PCRX | Sale | 27,853 | 59.94 | 1,669,369 |
| 2020-09-15 | PCRX | Sale | 27,853 | 59.41 | 1,654,607 |
| 2020-09-17 | PCRX | Option Ex | 27,871 | 39.76 | 1,108,039 |
| 2020-09-16 | PCRX | Option Ex | 27,853 | 39.76 | 1,107,323 |
| 2020-09-15 | PCRX | Option Ex | 27,853 | 39.76 | 1,107,323 |
| 2020-06-04 | PCRX | Sale | 2,402 | 46.33 | 111,287 |
| 2020-06-05 | PCRX | Sale | 5,904 | 48.61 | 286,993 |
| 2019-08-14 | PCRX | Sale | 6,252 | 39.49 | 246,891 |
| 2019-06-04 | PCRX | Sale | 2,529 | 42.91 | 108,519 |
| 2018-08-14 | PCRX | Sale | 4,773 | 47.04 | 224,521 |
| 2018-06-04 | PCRX | Sale | 2,040 | 33.02 | 67,360 |
| 2017-11-17 | PCRX | Sale | 7,857 | 40.00 | 314,280 |
| 2017-11-16 | PCRX | Sale | 2,143 | 40.01 | 85,741 |
| 2017-11-17 | PCRX | Option Ex | 7,857 | 25.37 | 199,332 |
| 2017-11-16 | PCRX | Option Ex | 2,143 | 25.37 | 54,367 |
| 2017-08-15 | PCRX | Sale | 3,461 | 36.75 | 127,191 |
| 2017-06-05 | PCRX | Sale | 1,877 | 43.32 | 81,313 |
| 2017-05-15 | PCRX | Option Ex | 21,041 | 10.19 | 214,470 |
| 2017-05-15 | PCRX | Sale | 21,041 | 50.86 | 1,070,145 |
| 2016-06-06 | PCRX | Sale | 600 | 47.20 | 28,319 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williams Kristen (Chief Administrative Officer of Pacira Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.